Why the study?
Does anakinra reduce cardiomyocyte apoptosis and improve ventricular remodeling in experimental animal models of acute myocardial infarction?
Does anakinra reduce cardiomyocyte apoptosis and improve ventricular remodeling in experimental animal models of acute myocardial infarction?
Anakinra administration within 24 hours of acute myocardial infarction significantly ameliorates ventricular remodeling by inhibiting cardiomyocyte apoptosis in experimental animal models.
No takes yet. Share an insight, caveat, or question.
May guide IL-1 inhibition research in MI models; leaves open translation to human therapy.
Abbate et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: